Prophylactic Risedronate for Patients With Peripheral Lung Tumors Treated With SBRT

NCT03861091 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

84

Enrollment

OTHER

Sponsor class

Conditions

Lung Neoplasm

Interventions

DRUG: risedronate
DRUG: Matching placebo

Sponsor

Wake Forest University Health Sciences

Collaborators

[object Object]